M&A Deal Summary

Genoptix Acquires Rosetta Genomics

On December 15, 2017, Genoptix acquired life science company Rosetta Genomics for 10M USD

Acquisition Highlights
  • This is Genoptix’s 1st transaction in the Life Science sector.
  • This is Genoptix’s largest (disclosed) transaction.
  • This is Genoptix’s 1st transaction in Israel.

M&A Deal Summary
Date 2017-12-15
Target Rosetta Genomics
Sector Life Science
Buyer(s) Genoptix
Deal Type Add-on Acquisition
Deal Value 10M USD
Advisor(s) Cantor Fitzgerald (Financial)

Target

Rosetta Genomics

Rehovot, Israel
Rosetta Genomics Ltd. is a developer and provider of microRNA-based and other molecular diagnostics. Rosetta’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Genoptix

Carlsbad, California, United States
Category Company
Founded 1999
Sector Healthcare Services
Employees508
DESCRIPTION

Genoptix, Inc. is one of the largest hematopathology testing laboratories in the U.S., providing thousands of oncologists and pathologists across the United States with comprehensive testing solutions in hematology and solid tumor molecular profiling. Genoptix, Inc. was founded in 1999 and is based in Carlsbad, California.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 2 of 2
Country (Israel) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-09-19 HistoRx

Branford, Connecticut, United States

HistoRx provides a solution to the need for quantitative, standardized and reproducible analysis of protein biomarkers in tissue.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-03-05 PersonalizeDx

Lake Forest, California, United States

PersonalizeDx Labs provides as a service molecular tests in pharmacogenomics, genetic disorders, oncology and infectious disease which will serve as a valuable aid for clinicians in diagnosing patients early and enable appropriate therapeutic intervention to enhance patient care.

Buy $1M
Mergr

Product

Company

Legal